tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VXRT Stock Latest News

Vaxart issues letter to shareholders related to reverse stock split proposal
The FlyVaxart issues letter to shareholders related to reverse stock split proposal
6h ago
VXRT
Vaxart Stock Approved for OTCQX Best Market
PremiumCompany Announcements
Vaxart Stock Approved for OTCQX Best Market
1M ago
8K
VXRT
Vaxart announces trading on OTCQX Best Market
PremiumThe Fly
Vaxart announces trading on OTCQX Best Market
1M ago
VXRT
OTC Markets Group welcomes Vaxart to OTCQX
PremiumThe Fly
OTC Markets Group welcomes Vaxart to OTCQX
1M ago
VXRT
Vaxart Stockholders Reject Reverse Stock Split Proposal
PremiumCompany Announcements
Vaxart Stockholders Reject Reverse Stock Split Proposal
2M ago
8K
VXRT
Vaxart’s Promising Developments and Market Potential Justify Buy Rating
PremiumRatingsVaxart’s Promising Developments and Market Potential Justify Buy Rating
2M ago
VXRT
Vaxart Announces Positive Phase 1 Norovirus Vaccine Results
Premium
Company Announcements
Vaxart Announces Positive Phase 1 Norovirus Vaccine Results
2M ago
8K
VXRT
Vaxart reports results from Phase 1 trial of second-gen norovirus vaccine
Premium
The Fly
Vaxart reports results from Phase 1 trial of second-gen norovirus vaccine
2M ago
VXRT
Vaxart Adjourns Annual Meeting for Reverse Stock Split
PremiumCompany Announcements
Vaxart Adjourns Annual Meeting for Reverse Stock Split
2M ago
8K
VXRT
Vaxart CSO Sean Tucker provides video update for shareholders
PremiumThe Fly
Vaxart CSO Sean Tucker provides video update for shareholders
2M ago
VXRT
Vaxart Discusses Reverse Stock Split and Capital Raise
PremiumCompany Announcements
Vaxart Discusses Reverse Stock Split and Capital Raise
2M ago
8K
VXRT
Vaxart Begins Phase 2b Trial for Oral COVID-19 Vaccine
PremiumCompany Announcements
Vaxart Begins Phase 2b Trial for Oral COVID-19 Vaccine
2M ago
8K
VXRT
Vaxart answers additional stockholder questions from retail investors
PremiumThe FlyVaxart answers additional stockholder questions from retail investors
2M ago
VXRT
Vaxart doses first patient in 10,000-participant part of COVID-19 trial
Premium
The Fly
Vaxart doses first patient in 10,000-participant part of COVID-19 trial
2M ago
VXRT
Vaxart Adjourns Annual Meeting for Stockholder Voting
Premium
Company Announcements
Vaxart Adjourns Annual Meeting for Stockholder Voting
3M ago
8K
VXRT
Vaxart Board Approves Reverse Split Proposal
PremiumCompany Announcements
Vaxart Board Approves Reverse Split Proposal
3M ago
8K
VXRT
Vaxart approves resolutions to narrow reverse split range, reduce shares
PremiumThe Fly
Vaxart approves resolutions to narrow reverse split range, reduce shares
3M ago
VXRT
Vaxart’s Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Vaxart’s Earnings Call: Growth Amid Challenges
3M ago
VXRT
Vaxart Receives BARDA Approval for Phase 2b Trial
PremiumCompany Announcements
Vaxart Receives BARDA Approval for Phase 2b Trial
3M ago
8K
VXRT
Vaxart receives BARDA approval to initiate dosing of Phase 2b COVID-19 trial
PremiumThe FlyVaxart receives BARDA approval to initiate dosing of Phase 2b COVID-19 trial
3M ago
VXRT
Vaxart announces publication of norovirus vaccine candidate data
Premium
The Fly
Vaxart announces publication of norovirus vaccine candidate data
3M ago
VXRT
Vaxart Reports Q1 2025 Progress and Financials
Premium
Company Announcements
Vaxart Reports Q1 2025 Progress and Financials
3M ago
VXRT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >